MedTrace Logo

Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

NCT00715351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342

Last updated 2016-11-25

No results posted yet for this study

Summary

This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control, weight change and hypoglycaemic effects in patients with type 2 diabetes with Levemir® compared to Insulatard® under normal clinical practice conditions.

Conditions

Interventions

DRUG

insulin detemir

Physician decides which insulin should be prescribed, selection of subjects will be at the discretion of participating physician

DRUG

insulin NPH

Physician decides which insulin should be prescribed, selection of subjects will be at the discretion of participating physician

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715351 on ClinicalTrials.gov